je.st
news
Biz Break: Pharmacyclics to sell in biggest biotech deal of the year, reports say
2015-03-05 00:53:04| Biotech - Topix.net
Today: Johnson & Johnson plans to buy Sunnyvale drugmaker Pharmacyclics for more than the $17 billion, according to the Financial Times. In a year that has already seen several blockbuster biotechnology deals, Sunnyvale drugmaker Pharmacyclics is set to be the biggest purchase so far, according to recent reports.
Tags: year
say
sell
reports
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||